Susquehanna International Group
SVA

Susquehanna International Group’s Sinovac Biotech, Ltd SVA Stock Holding History

Susquehanna International Group’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Hold
16,430
– – ﹤0.01% 12304
2025
Q4 		$106K Hold
16,430
– – ﹤0.01% 11420
2025
Q3 		$106K Hold
16,430
– – ﹤0.01% 11532
2025
Q2 		$106K Buy
+16,430
New +$106K ﹤0.01% 11759
2024
Q3 		– Sell
-16,430
Closed -$106K – 13473
2024
Q2 		$106K Hold
16,430
– – ﹤0.01% 10989
2024
Q1 		$106K Buy
+16,430
New +$106K ﹤0.01% 11181
2023
Q4 		– Sell
-16,430
Closed -$106K – 13816
2023
Q3 		$106K Hold
16,430
– – ﹤0.01% 10862
2023
Q2 		$106K Buy
+16,430
New +$106K ﹤0.01% 10909
2022
Q4 		– Sell
-16,430
Closed -$106K – 14730
2022
Q3 		$106K Sell
16,430
-200
-1% -$1.29K ﹤0.01% 11659
2022
Q2 		$108K Buy
+16,630
New +$108K ﹤0.01% 11409
2022
Q1 		– Sell
-16,430
Closed -$106K – 14684
2021
Q4 		$106K Sell
16,430
-200
-1% -$1.29K ﹤0.01% 12112
2021
Q3 		$108K Buy
16,630
+200
+1% +$1.3K ﹤0.01% 12029
2021
Q2 		$106K Hold
16,430
– – ﹤0.01% 12071
2021
Q1 		$106K Hold
16,430
– – ﹤0.01% 11833
2020
Q4 		$106K Hold
16,430
– – ﹤0.01% 10471
2020
Q3 		$106K Hold
16,430
– – ﹤0.01% 9891
2020
Q2 		$106K Hold
16,430
– – ﹤0.01% 9473
2020
Q1 		$106K Hold
16,430
– – ﹤0.01% 9286
2019
Q4 		$106K Hold
16,430
– – ﹤0.01% 9120
2019
Q3 		$106K Hold
16,430
– – ﹤0.01% 9540
2019
Q2 		$106K Sell
16,430
-3,590
-18% -$23.2K ﹤0.01% 9584
2019
Q1 		$130K Sell
20,020
-13,997
-41% -$92K ﹤0.01% 8143
2018
Q4 		$236K Buy
34,017
+5,520
+19% +$40.3K ﹤0.01% 7445
2018
Q3 		$219K Sell
28,497
-8,499
-23% -$61.3K ﹤0.01% 8059
2018
Q2 		$276K Sell
36,996
-9,689
-21% -$76.2K ﹤0.01% 8012
2018
Q1 		$402K Buy
46,685
+11,453
+33% +$94.4K ﹤0.01% 7068
2017
Q4 		$278K Buy
35,232
+22,973
+187% +$172K ﹤0.01% 7721
2017
Q3 		$86K Buy
+12,259
New +$83.7K ﹤0.01% 8410
2016
Q1 		– Sell
-16,118
Closed -$92K – 10487
2015
Q4 		$92K Sell
16,118
-3,817
-19% -$20.5K ﹤0.01% 8921
2015
Q3 		$101K Sell
19,935
-3,258
-14% -$17.3K ﹤0.01% 9132
2015
Q2 		$122K Sell
23,193
-2,042
-8% -$10.8K ﹤0.01% 9598
2015
Q1 		$125K Buy
25,235
+14,338
+132% +$70.6K ﹤0.01% 8887
2014
Q4 		$57K Sell
10,897
-4,544
-29% -$23.2K ﹤0.01% 9346
2014
Q3 		$74K Sell
15,441
-10,604
-41% -$56.9K ﹤0.01% 9146
2014
Q2 		$147K Sell
26,045
-2,319
-8% -$14.1K ﹤0.01% 9258
2014
Q1 		$204K Sell
28,364
-32,154
-53% -$213K ﹤0.01% 8208
2013
Q4 		$370K Buy
+60,518
New +$365K ﹤0.01% 7238

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Susquehanna International Group's SVA Position: Q1 2026 in Review

Susquehanna International Group held its Sinovac Biotech, Ltd (SVA) position steady in Q1 2026 at 16,430 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #12304.

Susquehanna International Group first reported a position in SVA in Q4 2013 and has held it in 37 quarters since. The position peaked at $402K in Q1 2018. 28 funds tracked by Wall St. Rank hold SVA as of Q1 2026.

  • Susquehanna International Group held 16,430 shares of Sinovac Biotech, Ltd worth $106K as of Q1 2026.
  • Susquehanna International Group left its Sinovac Biotech, Ltd share count unchanged in Q1 2026.
  • Sinovac Biotech, Ltd made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12304 holding.
  • Susquehanna International Group first reported a position in Sinovac Biotech, Ltd in Q4 2013 and has held it in 37 quarters since.
  • Susquehanna International Group's Sinovac Biotech, Ltd position peaked at $402K in Q1 2018.
  • 28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.